Deferiprone for the Prevention of Contrast-Induced Acute Kidney Injury

Clinical trial NCT01146925 · COMPLETED

Trial details

NCT number: NCT01146925
Sponsor: CorMedix Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Contrast-Induced Acute Kidney Injury

Start date: 2010-06-01
Primary completion: 2011-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.